Inicio
Explorar
nav.journalClub
Tendencias
Más
synapse
⌘+K
Idioma
Español
Advancing N = 1 therapies: Building ecosystems for personalized genetic medicine | Synapse
March 3, 2026
Advancing N = 1 therapies: Building ecosystems for personalized genetic medicine
JM
J. Moon
Boston Children's Hospital
MH
Miwa Higashi
CL
Claudia Lentucci
Boston Children's Hospital
Ver todo
Puntos clave
N=1 therapies enhance patient care through tailored treatments, offering specific genetic insights, and personalized strategies for individuals.
This approach analyzes individual genetic data and aligns it with healthcare interventions to improve treatment effectiveness and outcomes.
Ecosystem development involves collaboration among stakeholders to create personalized medicine frameworks and leverage genetic information.
Support for N=1 therapies may enable broader implementation of personalized strategies in clinical settings, improving health management.
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Cite This Study
Copy
Moon et al. (Mon,) studied this question.
synapsesocial.com/papers/69a75edac6e9836116a29cf7
https://doi.org/https://doi.org/10.1016/j.jns.2025.124471